使用茧状导管封堵器经导管封堵破裂的瓦氏窦瘤的安全性和可行性：即刻结果及中期随访

Safety and Feasibility of Transcatheter Interruption of Ruptured Sinus of Valsalva Aneurysm Using the Cocoon Duct Occluder: Immediate Results and Mid-Term Follow-Up.

作者信息

Sinha Santosh Kumar, Khanna Narendra Nath, Razi Mahmadula, Krishna Vinay, Jha Mukesh Jitendra, Mishra Vikas, Aggarwal Puneet, Goel Amit, Singh Karandeep, Thakur Ramesh, Rajan Lawrence, Varma Chandra Mohan

机构信息

Department of Cardiology, LPS Institute of Cardiology, G.S.V.M. Medical College, Kanpur, Uttar Pradesh 208002, India.

Apollo Indraprastha Hospital, New Delhi, India.

出版信息

Cardiol Res. 2017 Aug;8(4):154-160. doi: 10.14740/cr568w. Epub 2017 Aug 23.

BACKGROUND

Limited data are available regarding safety and feasibility of transcatheter interruption of ruptured sinus of Valsalva aneurysm (RSOVA) using the Cocoon duct occluder (CDO) with immediate and mid-term follow-up result.

METHODS

Transcatheter closure (TCC) was successfully done among eight patients, whereas five cases, not amenable to TCC, were referred for surgical correction among 13 consecutive patients of RSOVA at LPS Institute of Cardiology, Kanpur between January 2010 and March 2015.

RESULTS

Their mean age was 26.1 ± 6.9 years. Sites of rupture were from right coronary sinus (RCS) to right atrium (RA) in one (12.5%), right ventricle in one (12.5%), and non-coronary sinus to RA in six patients (75%). The defects (9 - 17 mm) were closed by CDO (12/10 - 20/18 mm) with 100% procedural success. During follow-up (9 - 26 months), there was no residual shunt, progression of AR, infective endocarditis or device embolization.

CONCLUSION

TCC of RSOVA appears to be a safe and feasible alternative to surgical therapy, with high technical success and excellent mid-term follow-up.

背景

关于使用茧形导管封堵器（CDO）经导管封堵破裂的瓦氏窦瘤（RSOVA）的安全性和可行性以及近期和中期随访结果的数据有限。

方法

2010年1月至2015年3月期间，坎普尔LPS心脏病学研究所连续13例RSOVA患者中，8例成功进行了经导管封堵术（TCC），而5例不适合TCC的患者则转诊接受手术矫正。

结果

他们的平均年龄为26.1±6.9岁。破裂部位为右冠状动脉窦（RCS）至右心房（RA）1例（12.5%），至右心室1例（12.5%），非冠状动脉窦至RA 6例（75%）。缺损（9 - 17毫米）用CDO（12/10 - 20/18毫米）封堵，手术成功率达100%。随访期间（9 - 26个月），无残余分流、主动脉反流进展、感染性心内膜炎或器械栓塞。